Xometry (NASDAQ:XMTR) CFO James Miln Sells 15,103 Shares

Xometry, Inc. (NASDAQ:XMTR) CFO James Miln sold 15,103 shares of the company’s stock in a transaction that occurred on Thursday, February 26th. The stock was sold at an average price of $43.46, for a total value of $656,376.38. Following the completion of the sale, the chief financial officer owned 173,123 shares in the company, valued at approximately $7,523,925.58. This represents a 8.02% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

James Miln also recently made the following trade(s):

• On Monday, February 2nd, James Miln sold 599 shares of Xometry stock. The stock was sold at an average price of $58.98, for a total value of $35,329.02.
• On Monday, January 5th, James Miln sold 6,203 shares of Xometry stock. The stock was sold at an average price of $66.51, for a total value of $412,561.53.
• On Friday, January 2nd, James Miln sold 598 shares of Xometry stock. The shares were sold at an average price of $61.80, for a total value of $36,956.40.

Xometry Trading Up 8.2%

NASDAQ:XMTR opened at $45.26 on Friday. The company has a market capitalization of $2.32 billion, a PE ratio of -37.10 and a beta of 0.86. The company has a quick ratio of 3.58, a current ratio of 3.76 and a debt-to-equity ratio of 1.18. Xometry, Inc. has a 52-week low of $18.59 and a 52-week high of $73.87. The stock has a fifty day simple moving average of $61.06 and a 200-day simple moving average of $56.04.

Xometry (NASDAQ:XMTR) last issued its quarterly earnings data on Tuesday, February 24th. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.12 by $0.04. The firm had revenue of $192.40 million for the quarter, compared to analysts’ expectations of $183.37 million. Xometry had a negative net margin of 8.99% and a negative return on equity of 5.49%. The firm’s revenue was up 29.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.06 EPS. On average, equities research analysts expect that Xometry, Inc. will post -0.66 earnings per share for the current fiscal year.

Key Stories Impacting Xometry

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: Citi and Wedbush remain constructive on Xometry despite trimming targets — Citi keeps a “buy” rating (target cut to $65) and Wedbush keeps an “outperform” rating (target cut to $60); these sustained bullish ratings temper the negative headlines and signal some analysts still see upside. Xometry (NASDAQ:XMTR) Price Target Cut to $65.00 by Analysts at Citigroup
• Positive Sentiment: Valuation story after strong 2025 results: a recent Yahoo piece assesses Xometry’s valuation in light of solid 2025 revenue growth and an upcoming CEO transition — this frames the company as still fundamentally improving even amid near-term noise. Assessing Xometry (XMTR) Valuation After Strong 2025 Results And Upcoming CEO Transition
• Neutral Sentiment: UBS nudged its target to $55 with a “neutral” rating — a modest change that neither strongly supports nor condemns near-term price action. Xometry (NASDAQ:XMTR) Given New $55.00 Price Target at UBS Group
• Neutral Sentiment: Royal Bank of Canada cut its target to $55 and now lists Xometry as “sector perform” — another mixed signal that reduces consensus upside but isn’t a full-scale downgrade. Xometry (NASDAQ:XMTR) Price Target Cut to $55.00 by Analysts at Royal Bank Of Canada
• Negative Sentiment: Market reaction / analyst downgrade headline — outlets reported Xometry trading down after analyst downgrades/target cuts, contributing to today’s weakness in the stock. Xometry (NASDAQ:XMTR) Trading Down 7.3% After Analyst Downgrade
• Negative Sentiment: Large insider sales by multiple senior executives (CEO, CFO, President, CTO and others) were disclosed on Feb. 26 — sizable, contemporaneous insider selling typically raises investor concern about insider sentiment and adds pressure to the share price. SEC filing (CEO sale) linked for reference. SEC filing – CEO sale
• Negative Sentiment: Reported Q4/2025 earnings call transcript excerpts were circulated saying Xometry missed EPS expectations — if investors treat those reports as accurate, they amplify downside pressure despite other outlets reporting a beat; the earnings narrative remains a source of confusion and volatility. Xometry, Inc. (NASDAQ:XMTR) Q4 2025 Earnings Call Transcript

Institutional Trading of Xometry

A number of institutional investors and hedge funds have recently made changes to their positions in XMTR. Kemnay Advisory Services Inc. purchased a new position in shares of Xometry in the 4th quarter worth $28,000. Quantbot Technologies LP acquired a new stake in Xometry during the third quarter worth about $30,000. Advisors Asset Management Inc. raised its holdings in shares of Xometry by 68.3% in the 2nd quarter. Advisors Asset Management Inc. now owns 1,015 shares of the company’s stock worth $34,000 after purchasing an additional 412 shares during the period. Westend Capital Management LLC acquired a new position in shares of Xometry in the 3rd quarter valued at about $41,000. Finally, GAMMA Investing LLC lifted its stake in shares of Xometry by 26.5% in the 4th quarter. GAMMA Investing LLC now owns 773 shares of the company’s stock valued at $46,000 after purchasing an additional 162 shares in the last quarter. 97.31% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have weighed in on XMTR. Cantor Fitzgerald raised their price target on Xometry from $41.00 to $60.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 5th. UBS Group boosted their target price on shares of Xometry from $54.00 to $55.00 and gave the company a “neutral” rating in a research note on Wednesday. William Blair reaffirmed an “outperform” rating on shares of Xometry in a research note on Tuesday. The Goldman Sachs Group boosted their price objective on shares of Xometry from $49.00 to $56.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. Finally, Royal Bank Of Canada reduced their price objective on shares of Xometry from $64.00 to $55.00 and set a “sector perform” rating on the stock in a research note on Wednesday. Five investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Xometry has an average rating of “Hold” and an average price target of $62.00.

Xometry Company Profile

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.